Daniel Souroujon

Daniel Souroujon

Auto-generated profile, based on publicly available information

Daniel Souroujon

Metaflow Ltd, HaArba'a St 30, Tel-Aviv, IL

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
APAmichai Perlman
Amichai Perlman
AZAlina Vodonos Zilberg
Alina Vodonos Zilberg
PBPeter Bak
Peter Bak
MDMichael Dreyfuss
Michael Dreyfuss
MLMaya Leventer-Roberts
Maya Leventer-Roberts
DSDaniel Souroujon
Daniel Souroujon
Background: Patient-facing digital health tools have been promoted to help patients manage concerns related to COVID-19 and to enable remote care and self-care during the COVID-19 pandemic. It has also been suggested that these tools can help further our understanding of the clinical characteristics of this new disease. However, there is limited information on the characteristics and use patterns of these tools in practice. Objective: The aims of this study are to describe the characteristics of people who use digital health tools to address COVID-19–related concerns; explore their self-reported symptoms and characterize the association of these symptoms with COVID-19; and characterize the recommendations provided by digital health tools. Methods: This study used data from three digital health tools on the K Health app: a protocol-based COVID-19 self-assessment, an artificial intelligence (AI)–driven symptom checker, and communication with remote physicians. Deidentified data were extracted on the demographic and clinical characteristics of adults seeking COVID-19–related health information between April 8 and June 20, 2020. Analyses included exploring features associated with COVID-19 positivity and features associated with the choice to communicate with a remote physician. Results: During the period assessed, 71,619 individuals completed the COVID-19 self-assessment, 41,425 also used the AI-driven symptom checker, and 2523 consulted with remote physicians. Individuals who used the COVID-19 self-assessment were predominantly female (51,845/71,619, 72.4%), with a mean age of 34.5 years (SD 13.9). Testing for COVID-19 was reported by 2901 users, of whom 433 (14.9%) reported testing positive. Users who tested positive for COVID-19 were more likely to have reported loss of smell or taste (relative rate [RR] 6.66, 95% CI 5.53-7.94) and other established COVID-19 symptoms as well as ocular symptoms. Users communicating with a remote physician were more likely to have been recommended by the self-assessment to undergo immediate medical evaluation due to the presence of severe symptoms (RR 1.19, 95% CI 1.02-1.32). Most consultations with remote physicians (1940/2523, 76.9%) were resolved without need for referral to an in-person visit or to the emergency department. Conclusions: Our results suggest that digital health tools can help support remote care and self-management of COVID-19 and that self-reported symptoms from digital interactions can extend our understanding of the symptoms associated with COVID-19.

10 April 2024 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
DDDorit Dil-Nahlieli
Dorit Dil-Nahlieli
ABArie Ben-Yehuda
Arie Ben-Yehuda
DSDaniel Souroujon
Daniel Souroujon
EHEytan Hyam
Eytan Hyam
SSSigal Shafran-Tikvah
Sigal Shafran-Tikvah

1 April 2024 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
SYShlomo Yeshurun
Shlomo Yeshurun
TCTomer Cramer
Tomer Cramer
DSDaniel Souroujon
Daniel Souroujon
MMMerav Mor
Merav Mor
Background: Metabolic flexibility is the ability of the body to rapidly switch between fuel sources based on their accessibility and metabolic requirements. High metabolic flexibility is associated with improved health outcomes and a reduced risk of several metabolic disorders. Metabolic flexibility can be improved through lifestyle changes, such as increasing physical activity and eating a balanced macronutrient diet. Lumen is a small handheld device that measures metabolic fuel usage through exhaled carbon dioxide (CO2), which allows individuals to monitor their metabolic flexibility and make lifestyle changes to enhance it. Objective: This retrospective study aims to examine the postprandial CO2 response to meals logged by Lumen users and its relationship with macronutrient intake and BMI. Methods: We analyzed deidentified data from 2607 Lumen users who logged their meals and measured their exhaled CO2 before and after those meals between May 1, 2023, and October 18, 2023. A linear mixed model was fitted to test the association between macronutrient consumption, BMI, age, and gender to the postprandial CO2 response, followed by a 2-way ANOVA. Results: The model demonstrated significant associations (P<.001) between CO2 response after meals and both BMI and carbohydrate intake (BMI: β=–0.112, 95% CI –0.156 to –0.069; carbohydrates: β=0.046, 95% CI 0.034-0.058). In addition, a 2-way ANOVA revealed that higher carbohydrate intake resulted in a higher CO2 response compared to low carbohydrate intake (F2,2569=24.23; P<.001), and users with high BMI showed modest responses to meals compared with low BMI (F2,2569=5.88; P=.003). Conclusions: In this study, we show that Lumen’s CO2 response is influenced both by macronutrient consumption and BMI. The results of this study highlight a distinct pattern of reduced metabolic flexibility in users with obesity, indicating the value of Lumen for assessing postprandial metabolic flexibility.

2 September 2025 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
SYShlomo Yeshurun
Shlomo Yeshurun
TCTomer Cramer
Tomer Cramer
DSDaniel Souroujon
Daniel Souroujon
MMMerav Mor
Merav Mor
Background: The increasing prevalence of obesity and related metabolic disorders has highlighted the need for innovative tools to monitor and manage metabolic health. The Lumen device offers a novel approach to assess the metabolic state through exhaled carbon dioxide (CO2) measurements, providing real-time feedback via a mobile app. This app-driven experience allows users to track their metabolic state and receive personalized nutrition and lifestyle recommendations, potentially supporting long-term metabolic health improvements. Objective: This study aimed to investigate the association between the previous day’s carbohydrate consumption with fasted, exhaled CO2 levels in female and male Lumen users while also examining the influence of fasting duration, BMI, and age. Methods: We conducted a retrospective, observational study using deidentified data from 48,058 Lumen users, comprising 707,372 fasted sessions. Separate linear mixed models were fitted for female (n=520,269 sessions) and male (n=187,103 sessions) users due to observed sex differences in metabolism. User ID was included as a random effect to account for repeated measures. The models analyzed the relationship between fasted %CO2 levels and reported carbohydrate intake, fasting duration, BMI, and age. Results: Higher reported carbohydrate intake from the previous day was significantly associated with increased morning %CO2 levels in both male and female users (β=.032; P<.001; Cohen d=0.0691 in women and β=.024; P<.001; Cohen d=0.0534 in men), while a longer fasting duration was linked to decreased %CO2 levels in both sexes (β=−.017; P<.001 for both and Cohen d=−0.0374 in women and Cohen d=−0.0382 in men). A higher BMI was associated with elevated %CO2 levels in both sexes (β=.018; P<.001; Cohen d=0.0390 in women and β=.017; P<.001; Cohen d=0.0384 in men). Age had a statistically significant but modest effect in women (β=.008; P<.001; Cohen d=0.0180), whereas the effect size was minimal and did not meet the stricter significance threshold in men (β=.001; P=.02; Cohen d=0.0016). Cohen d values indicated that reported carbohydrate intake had the strongest effect size, while fasting duration and BMI had relatively smaller effects in both models. Conclusions: The Lumen device is able to detect changes in fasted %CO2 levels based on the previous day’s reported carbohydrate intake and fasting duration with sex-specific metabolic responses. These findings highlight the potential of Lumen as a personalized metabolic health monitoring tool, providing insights into the influence of dietary intake and fasting on metabolic state. Future research should investigate the hormonal and physiological mechanisms contributing to the observed sex differences and assess the long-term impact of app-guided metabolic feedback on user behaviors and metabolic health outcomes.

17 June 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
EAEden Avnat
Eden Avnat
MSMichael Samin
Michael Samin
DJDaniel Ben Joya
Daniel Ben Joya
ESEyal Schneider
Eyal Schneider
EYElia Yanko
Elia Yanko
DSDaniel Souroujon
Daniel Souroujon
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Evidence-based clinical intake tools (EBCITs) are structured assessment tools used to gather information about patients and help healthcare providers make more informed decisions. The growing demand for personalized medicine, along with the big data revolution, have rendered EBCITs a promising solution. EBCITs have the potential to provide comprehensive and individualized assessments of symptoms, enabling accurate and timely diagnosis, while contributing to the grounding of medical care. Objective: This work examines whether EBCITs cover data concerning disorders and symptoms to a similar extent as physicians, thus can reliably address medical conditions in clinical settings. We also explore the potential of EBCITs to discover and ground real prevalence of symptoms in different disorders thereby expanding medical knowledge and further support medical diagnoses made by physicians. Methods: Between August 1, 2022, and January 15, 2023, patients who used the services of a virtual healthcare (VH) provider in the USA were first assessed by the Kahun EBCIT. Kahun platform gathered, documented, and analyzed the information from the sessions and its clinical findings. In this study, we estimated the prevalence of patients' symptoms in medical disorders, using two datasets. The first set analyzed symptoms prevalence, as determined by the Kahun's knowledge engine. The second set analyzed symptoms prevalence, relying solely on data from the VH patients gathered by Kahun. The difference in variance between these two prevalence datasets, helped us assess Kahun's ability to incorporate new data, while integrating existing knowledge. To analyze the comprehensiveness of the Kahun's knowledge engine, we compared how well it covers weighted data for the symptoms and disorders found in the 2019 National Ambulatory Medical Care Survey (NAMCS). To assess Kahun's diagnosis accuracy, physicians independently diagnosed 250 of Kahun-VH’s sessions. Their diagnoses were compared with Kahun's diagnoses. Results: As part of this work, 2,550 patients used Kahun to complete a full assessment, among them 1,714 females and 836 males. Kahun collected 314 different chief complaints and proposed 108,523 suggestions related to symptoms during the intake process. At the end of the intake process, 6,496 conditions were presented to the caregiver. Kahun covered 94% (526,157,569/562,150,572) of the weighted symptoms and 91% (1,582,637,476/173,4783,244) of the weighted disorders in NAMCS 2019. In 90% (224/250) of the sessions, at least one identical disorder suggested by both the physicians and Kahun, with total accuracy rate of 72% (367/507). Kahun’s engine yielded 519 prevalences while the Kahun-VH cohort yielded 599; 156 prevalences were unique to the latter and 443 prevalences were shared by both databases. Conclusions: ECBITs, such as Kahun, encompass extensive amounts of knowledge and could serve as a reliable database for inferring medical insights and diagnosis. Using this credible database, potential prevalence of symptoms in different disorders were discovered or grounded. This highlights the ability of ECBITs to refine the understanding of relationships between disorders and symptoms, which further supports physicians in medical diagnosis.

14 March 2024 in Journal of Telemedicine and Telecare
Verified
Journal Article
Closed access
APAmichai Perlman
Amichai Perlman
YPYishai Pickman
Yishai Pickman
MDMichael Dreyfuss
Michael Dreyfuss
IMItay Manes
Itay Manes
PBPeter Bak
Peter Bak
DZDan Zeltzer
Dan Zeltzer
Objective: To evaluate the clinical outcomes of a remote mental health program for managing anxiety and depression, primarily using asynchronous digital communication. Methods: This retrospective cohort study examined U.S. adults seeking remote care for anxiety and depression from January 2021 to May 2022. The program involves clinician-led assessment, patient education, medication management, and ongoing monitoring, primarily via text. Anxiety and depression were measured using Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder (GAD-7) scores. Outcomes examined were changes in scores, 50% score improvement rate, and remission rate (score <5) at 1, 3, and 6 months. Results: During the period evaluated, 11,844 program participants met the inclusion criteria. Most were female (n = 8328, 70.3%); their age ranged from 18–82 years (median 31 years). At baseline, median PHQ-9 and GAD-7 scores were 13 (IQR 9–17); 67% and 69% met score criteria for depression and anxiety, respectively. Most participants (80%) were prescribed a selective serotonin reuptake inhibitor (SSRI). By one month, average PHQ-9 and GAD-7 scores decreased significantly by 9.2 and 9.1 points (both p < .01). At 1-month follow-up, the 50% score improvement rate was 66% for PHQ-9 and 69% GAD-7 ( p < .01). Scores continued to decrease with follow-up. At 3 months, over half achieved remission (percent [95% CI]: 52% [51–54] for anxiety, 53% [52–55] for depression). Similar improvement was observed at 6 months and in sensitivity analyses accounting for loss to follow-up. Conclusions: Use of a remote mental health program with digital tools was associated with significant clinical improvement in anxiety and depression. Challenges remain in maintaining patient engagement and ensuring appropriate care quality monitoring in digital mental health programs. Additional research comparing remote digital care to traditional in-person models is warranted. Studies should examine long-term outcomes, optimal care protocols, and the challenges to integrating these programs into existing healthcare systems and ensuring equitable access.